An open-label , dose-optimization phase ( n = @ ) was followed by a randomized phase ( n = @ ) , in which patients who were HER@ positive by fluorescence in situ hybridization ( FISH ) received lapatinib @,@ mg once per day plus once-per-week paclitaxel @ mg/m ( @ ) or paclitaxel alone .